{
  "$type": "site.standard.document",
  "bskyPostRef": {
    "cid": "bafyreiexzvnmnmo2syhjayetlysgy6smzhjykdzqfzbl6vptdoccjejnia",
    "uri": "at://did:plc:5ka4qkui7nvjms7idhte2m4o/app.bsky.feed.post/3mo2gcivcop52"
  },
  "coverImage": {
    "$type": "blob",
    "ref": {
      "$link": "bafkreie6bfpxhc3wbzevtrllp6cb6qrjnx2d4zgyo6rfbnnyax3wzthani"
    },
    "mimeType": "image/jpeg",
    "size": 115752
  },
  "path": "/2026/06/11/biotech-news-novartis-doubles-down-on-molecular-glue-strategy/?utm_campaign=rss",
  "publishedAt": "2026-06-11T14:11:20.000Z",
  "site": "https://www.statnews.com",
  "tags": [
    "Biotech",
    "Business",
    "Pharma",
    "The Readout",
    "biotechnology",
    "drug development",
    "Drug prices",
    "research"
  ],
  "textContent": "Seniors' drug costs rise sharply, Enliven's leukemia drugs, and more biotech news from The Readout",
  "title": "STAT+: Novartis doubles down on molecular glue strategy",
  "updatedAt": "2026-06-11T14:11:24.000Z"
}